AzTrials
AzTrials

Preterm LaborNCT03610841

Evaluation of the Possible Relationship Between Periodontal Disease and Preterm Labor

An observational study of Preterm Labor and Periodontal Disease, run by Recep Tayyip Erdogan University Training and Research Hospital at 6 sites in 2 countries.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The primary objective of the study is to assess the incidence and severity of the periodontal infection of patients with preterm labor. The secondary objective of the study is to analyze the relationship between preterm labor and periodontal infection, using clinical, biochemical and microbiological methods. Read more about this study

Who is it for?
Ages 21 to 34 years, women only
Conditions the study is for
Preterm Labor, Periodontal Disease
What is being tested?
preterm labor and healthy
How many people
100 participants
Where
6 sitesin 2 countries
Study dates
17 Feb 2018to 15 Dec 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 34 years
  • Women only
  • Adult

Study population: The study is planned to be a case-control study. Workgroup consists of 50 patients which diagnosed with preterm labor between the age of 21 and 34. Control group consists of healthy females 24-36 6/7 weeks of pregnant with no history of preterm labor.

Who may be able to join

  • pregnant women with preterm labor
  • 37. weeks of pregnant women with no history of preterm labor

Who cannot join

  • Genitourinary infection
  • pregnancy or pre-pregnancy hypertension
  • HIV infection
  • diabetes mellitus
  • multiple pregnancy, preterm labor / low birth weight
  • smoker and alcohol use history
Show all 14Show fewer
  • IVF pregnancy
  • placental, cervical and uterine anomalies
  • pregnancy with intrauterine growth retardation
  • pregnancies with congenital or chromosomal fetal anomalies
  • significant vaginal bleeding
  • infertility stories
  • drug addicts
  • poor socioeconomic level

Trial locations and contacts

6 sites in 2 countries.

Gül Yıldız Telatar, Dr. contact

05365404555

gulyildiz@gmail.com

Beril Gürlek, Dr. contact

05535979403

berilsem@yahoo.com

6 sites in 2 countries

Turkey (Türkiye)5 sites, 2 recruiting
  • Ege University Dentistry Faculty

    Izmir

    : Nurcan Buduneli, Prof. Dr., 05326962525, nurcanbuduneli@yahoo.com

    Önder Gürlek, Dr., 05057555888, dr.ondergurlek@hotmail.com

    Recruiting
  • İzmir Health Sciences University, Tepecik Training and Research Hospital Department of Obstetrics and Gynecology

    Izmir

    Murat Alan, Dr., 05333952097, gozdealan@hotmail.com

    Recruiting
  • Recep Tayyip Erdogan University Dentistry Faculty

    Rize, 53000

    Active, not recruiting
  • Recep Tayyip Erdogan University Faculty of Medicine

    Rize, 53000

    Active, not recruiting
  • Recep Tayyip Erdogan University

    Rize, 53000

    Active, not recruiting

Other trials in Turkey (Türkiye)

United Kingdom1 site
  • Glaskow Dental School , School of Medicine University of Glasgow

    Glaskow

    Active, not recruiting

Other trials in United Kingdom

About this study

Official title: Evaluation of the Possible Relationship Between Preterm Labor and Periodontal Disease With Clinical Periodontal, Biochemical and Microbiological Data

The primary objective of the study is to assess the incidence and severity of the periodontal infection of patients with preterm labor.

The secondary objective of the study is to analyze the relationship between preterm labor and periodontal infection, using clinical, biochemical and microbiological methods.

Read the detailed description

Preterm infants are born prior to completion of 37 weeks of gestation. Periodontal disease is a subclinical and persistent infection source which induces the systemic inflammatory reactions and increases the risk of preterm labor. It is believed that the results will set light to the etiology of preterm labor and will help to develop strategies to prevent the disease.

Being tested
preterm labor, healthy
Medical subject headings
Obstetric Labor, Premature, Periodontal Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • preterm laborDiagnostic test

    Also called blood sample, urine test

    liver function tests, kidney function tests and platelets measures the ratio of protein to creatinine

  • healthyDiagnostic test

    Also called blood sample, urine test

    liver function tests, kidney function tests and platelets measures the ratio of protein to creatinine

Study groups in NCT03610841
Study groupRoleWhat they receive
preterm laborWorkgroup consists of patients which diagnosed with preterm labor between the age of 21 and 34
Receives: Diagnostic Test: preterm labor; Diagnostic Test: healthy
healthy24-36 6/7 weeks of pregnant between the age of 21 and 34
Receives: Diagnostic Test: preterm labor; Diagnostic Test: healthy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. prostaglandin E2

    prostaglandin E2 levels will be evaluated in salivary, serum and placenta samples using ELISA test Normal value:29-97 pg / ml

    Measured: 1 Day

  2. TNF-Alpha

    TNF-Alpha levels will be evaluated in salivary, serum and placenta samples using ELISA test Normal value:42-203pg/ml

    Measured: 1 day

  3. IL-1beta

    IL-1beta levels will be evaluated in salivary, serum and placenta samples using ELISA test Normal value:3-227pg/ml

    Measured: 1 day

Secondary outcomes (2)
  1. Porphyromonas gingivalis

    Presence of Porphyromonas gingivalis will be checked by rPCR method. Score 1: Present Score 2: None

    Measured: 1 Day

  2. Tannerella Forsythia

    Presence of Tannerella Forsythia will be checked by rPCR method. Score:1 Present. Score 2: None

    Measured: 1 Day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Aug 2018
  2. Study start17 Feb 2018
  3. Primary completion17 Sep 2018 (estimated)
  4. Study completion15 Dec 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03610841
Sponsor's protocol ID
40465587-26
Status last verified
Jul 2018
First submitted
17 Jul 2018
Last updated
1 Aug 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Data will be available within 6 months of study completion

Publications

  • Puertas A, Magan-Fernandez A, Blanc V, Revelles L, O'Valle F, Pozo E, Leon R, Mesa F. Association of periodontitis with preterm birth and low birth weight: a comprehensive review. J Matern Fetal Neonatal Med. 2018 Mar;31(5):597-602. doi: 10.1080/14767058.2017.1293023. Epub 2017 Feb 28.

    PubMed 28282773

Questions about this trial

What is this clinical trial studying?

An observational study of Preterm Labor and Periodontal Disease, run by Recep Tayyip Erdogan University Training and Research Hospital at 6 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 Aug 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in Turkey (Türkiye), United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Gül Yıldız Telatar, Dr. (05365404555, gulyildiz@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

prostaglandin E2 (time frame: 1 Day). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03610841, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Aug 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in